Part 3: Following the Spend
Healthcare spending is increasingly driven by six high‑cost specialties, with nephrology emerging as the leader in value‑based care adoption. Between 2020 and 2023, specialty spending grew 35% faster than the overall market, and about 30‑35% of kidney patients are now managed under total‑cost‑of‑care contracts. The combined cardio‑kidney spend totals roughly $608 billion, highlighting a massive addressable market. Investors have deployed $1.6 billion into kidney‑care platforms and $10 billion into broader cardiometabolic solutions, signaling confidence in scalable, outcome‑focused models.
Inside Dallas Renal Group’s AI Rollout
In this episode, Dallas Renal Group’s CEO Srinivas Tanda, nephrologist Dr. Kendall Shastri, and Confido Health’s co‑founder Vishar discuss rolling out agentic AI to handle patient‑access workflows in a multi‑site nephrology practice. They detail the pre‑AI pain points—over 40,000 monthly...
Brief: Can Medicare Help More Patients Stay on Home Dialysis?
Rep. Carol Miller introduced the Improving Home Dialysis Act (H.R.8875), which would add two Medicare‑covered support services—staff‑assisted home‑dialysis respite care and up to four renal mental‑health sessions—for patients starting home dialysis. A budget‑neutrality waiver means the new payments would be...
Biogen, Vantive, Monogram, and Dozens More Are Hiring
A curated bi‑weekly roundup highlights dozens of senior openings across the kidney‑focused biotech and medtech sector. Companies such as Biogen, Akebia Therapeutics, Monogram Health, Vantive and Vertex are adding leadership roles in research, procurement, strategic initiatives, environmental health & safety,...
Redefining Success in Transplant Medicine
In this episode of Signals KOLs, transplant nephrologist Dr. Deirdre Sawinski, industry veteran Steve Risk (SVP Medical Affairs at Veloxys), and patient‑physician Sejal Patel discuss the stagnant long‑term outcomes in kidney transplantation despite excellent short‑term success. They highlight how current...
Part 2: The Spaces Between
Bright Frontier, a new platform founded by Janis Naeve and Tim Fitzpatrick, maps systemic gaps in kidney and cardiometabolic (CKM) care and proposes four critical "bridges"—signal to decision, decision to action, action to accountability, and accountability to signal. The analysis...
Inside the RPA's Leadership Development Program
In this episode Tim Fitzpatrick chats with three early‑career nephrologists—Kinjal Shastri, Amandeep (Aman) Raman, and Raman Benaktar—about their recent participation in the Renal Physicians Association’s Leadership Development Program. The fellows explain that the year‑long fellowship pairs them with senior mentors,...